scholarly journals Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries

BMJ Open ◽  
2018 ◽  
Vol 8 (7) ◽  
pp. e020618 ◽  
Author(s):  
Hsiang-Lin Lee ◽  
Cheng-Ming Peng ◽  
Cheng-Yu Huang ◽  
Shin-Yi Wu ◽  
Ming-Chang Tsai ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Healthcare Disparities ◽  
Secondary Analysis ◽  
Mortality Rates ◽  
Inclusion Criteria ◽  
Database Analysis ◽  
Cross Sectional ◽  
Incidence And Mortality ◽  
Similar Association ◽  
Colorectal Cancer Mortality

ObjectiveThe colorectal cancer mortality-to-incidence ratio (MIR) can reflect healthcare disparities. However, a similar association has not yet been established between the MIR of pancreatic cancer and healthcare disparities.MethodsIn this study, the incidence and mortality rates of pancreatic cancer were obtained from the GLOBOCAN 2012 database. The WHO rankings and total expenditures on health/gross domestic product (e/GDP) were obtained from a public database. Linear regression was performed to determine correlations between the variables.Results57 countries met the inclusion criteria according to the data quality. Developed regions (Europe and the Americas) had high pancreatic cancer incidence and mortality rates. The MIRs were over 0.90 in all regions. No significant correlation was found between MIRs and the WHO rankings, e/GDP or per capita total expenditure on health for analysis in the 57 countries, indicating no association between MIRs and cancer care disparities for pancreatic cancer.ConclusionsThe MIR variations for pancreatic cancer do not correlate with healthcare disparities among countries. Further investigation is necessary to confirm this observation with secondary analysis of databases.

scholarly journals Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: An administrative registry data analysis

2020 ◽  
Author(s):  
Juliana Alexandra Hernández Vargas ◽  
Paula Ximena Ramírez Barbosa ◽  
Ana Milena Gil Quijano ◽  
Ana María Valbuena García ◽  
Lizbeth Acuña Merchán ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Incidence ◽  
Public Health Problem ◽  
Mortality Rates ◽  
Eastern Region ◽  
Global Public Health ◽  
Cervical Cancer Incidence ◽  
Mortality Trends ◽  
Cross Sectional ◽  
Incidence And Mortality

Abstract Background Cancer is widely recognized as a global public health problem. Breast, prostate and cervical cancer are among the most frequent types in developing countries. Assessing their incidence and mortality by regions and municipalities is important to guide evidence-based health policy. Our aim was to describe the incidence and mortality trends for breast, cervical and prostate cancer across regions and municipalities in Colombia during 2018. Methods We performed a cross-sectional analysis with data from people with breast, prostate or cervical cancer, reported to the National Administrative Cancer Registry during 2018. A descriptive analysis was performed. Age-standardized incidence and mortality rates were estimated at national, regional and municipal levels. Finally, we identify the regions and municipalities with significantly higher or lower incidence and mortality rates compared to national estimations. Results Breast cancer was the most frequent type among all new cases and deaths in Colombia. Breast, prostate and cervical cancer incidence and mortality rates were: 18,69 (CI 95%: 18,15–19,25) and 10,48 (CI 95%: 10,07–10,91); 11,34 (CI 95%: 10,90 − 11,78) and 7,58 (CI 95%: 7,22 − 7,96); 5,93 (CI 95%: 5,62 − 6,25) and 4,31 (CI 95%: 4,05 − 4,58), respectively. Eastern region had both, incidence and mortality rates, significantly lower than national for all types of cancer. By municipalities, there were a heterogeneous pattern. Nonetheless, Agua de Dios (Cundinamarca), had one of the highest incidence rates for all types. Conclusions We observed clear differences in cancer incidence and mortality across regions and municipalities, depending on each type of cancer. Our findings are important to improve screening coverage, early detection and treatment in the country.

scholarly journals Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: An administrative registry data analysis

2020 ◽  
Author(s):  
Juliana Alexandra Hernández Vargas ◽  
Paula Ximena Ramírez Barbosa ◽  
Ana Milena Gil Quijano ◽  
Ana María Valbuena García ◽  
Lizbeth Acuña Merchán ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Incidence ◽  
Public Health Problem ◽  
Mortality Rates ◽  
Eastern Region ◽  
Global Public Health ◽  
Cervical Cancer Incidence ◽  
Mortality Trends ◽  
Cross Sectional ◽  
Incidence And Mortality

Abstract Background: Cancer is widely recognized as a global public health problem. Breast, prostate, and cervical cancer are among the most frequent types in developing countries. Assessing their incidence and mortality by regions and municipalities is important to guide evidence-based health policy. Our aim was to describe the incidence and mortality trends for breast, cervical, and prostate cancer across regions and municipalities in Colombia during 2018.Methods: We performed a cross-sectional analysis with data from people with breast, prostate, or cervical cancer, reported to the National Administrative Cancer Registry during 2018. A descriptive analysis was performed. Age-standardized incidence and mortality rates were estimated at national, regional, and municipal levels. Finally, we identify the regions and municipalities with significantly higher or lower incidence and mortality rates compared to national estimations. Results: Breast cancer was the most frequent type among all new cases and deaths in Colombia. Breast, prostate and cervical cancer incidence and mortality rates per 100,000 were: 18.69 (CI 95%: 18.15-19.25) and 10.48 (CI 95%: 10.07-10.91); 11.34 (CI 95%: 10.90-11.78) and 7.58 (CI 95%: 7.22-7.96); 5.93 (CI 95%: 5.62-6.25) and 4.31 (CI 95%: 4.05-4.58), respectively. Eastern region had both, incidence and mortality rates, significantly lower than national for all types of cancer. By municipalities, there was a heterogeneous pattern. Nonetheless, Agua de Dios (Cundinamarca), had one of the highest incidence rates for all types. Conclusions: We observed clear differences in cancer incidence and mortality across regions and municipalities, depending on each type of cancer. Our findings are important to improve screening coverage, early detection, and treatment in the country.

Worldwide incidence and mortality of ovarian cancer and human development index: an ecology study in 2018

2020 ◽  
Author(s):  
Elham Goodarzi ◽  
Hasan Naemi ◽  
Isan Darvishi ◽  
Seyyede Maryam Bechashk ◽  
Zaher Khazaei
Keyword(s):  
Ovarian Cancer ◽  
Cancer Incidence ◽  
Mortality Rates ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Distribution Maps ◽  
Cancer Data ◽  
Incidence Data ◽  
Incidence And Mortality ◽  
Regression Tests

Abstract Background: Ovarian cancer is the seventh most common cancer among women, accounting for about 4% of all cancers associated with women.Method: This is a descriptive cross-sectional study based on extraction of cancer incidence data and cancer mortality rates from the Global Cancer Data in 2018. The incidence and mortality rates and ovarian cancer distribution maps were drawn for World countries. To analyze data, correlation test and regression tests were used to evaluate the correlation between its incidence and mortality with HDI.Results: The results showed that there was a positive and significant correlation between ovarian cancer incidence (R = 0.409, P <0.0001) and mortality (R = 0.193, P <0.05) with HDI. The results showed that there was a positive and significant correlation between incidence with GNI ,MYS ,LEB and EYS ( P <0.0001). The results also demonstrated that there was a positive and significant correlation between mortality and GNI, MYS, LEB and EYS ( P <0.05).The linear regression model showed that a higher MYS [B = 0.2, CI95%: (- 0.03,0.5)] significantly increased the incidence of ovarian cancer and increased MYS [B = 0.2, CI95% (0.03, 0.4)] increased mortality.Conclusion: Given the positive and significant correlation between ovarian cancer incidence and mortality with HDI, attention to risk factors in these countries can be effective in curbing its incidence and mortality.

scholarly journals Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Juliana Alexandra Hernández Vargas ◽  
Paula Ximena Ramírez Barbosa ◽  
Ana Milena Gil Quijano ◽  
Ana María Valbuena ◽  
Lizbeth Acuña ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Incidence ◽  
Public Health Problem ◽  
Mortality Rates ◽  
Eastern Region ◽  
Global Public Health ◽  
Cervical Cancer Incidence ◽  
Mortality Trends ◽  
Cross Sectional ◽  
Incidence And Mortality

Abstract Background Cancer is widely recognized as a global public health problem. Breast, prostate, and cervical cancer are among the most frequent types in developing countries. Assessing their incidence and mortality by regions and municipalities is important to guide evidence-based health policy. Our aim was to describe the incidence and mortality trends for breast, cervical, and prostate cancer across regions and municipalities in Colombia during 2018. Methods We performed a cross-sectional analysis with data from people with breast, prostate, or cervical cancer, reported to the National Administrative Cancer Registry during 2018. A descriptive analysis was performed. Age-standardized incidence and mortality rates were estimated at national, regional, and municipal levels. Finally, we identify the regions and municipalities with significantly higher or lower incidence and mortality rates compared to national estimations. Results Breast cancer was the most frequent type among all new cases and deaths in Colombia. Breast, prostate and cervical cancer incidence and mortality rates per 100,000 were: 18.69 (CI 95%: 18.15–19.25) and 10.48 (CI 95%: 10.07–10.91); 11.34 (CI 95%: 10.90–11.78) and 7.58 (CI 95%: 7.22–7.96); 5.93 (CI 95%: 5.62–6.25) and 4.31 (CI 95%: 4.05–4.58), respectively. Eastern region had both, incidence and mortality rates, significantly lower than national for all types of cancer. By municipalities, there was a heterogeneous pattern. Nonetheless, Agua de Dios (Cundinamarca), had one of the highest incidence rates for all types. Conclusions We observed clear differences in cancer incidence and mortality across regions and municipalities, depending on each type of cancer. Our findings are important to improve screening coverage, early detection, and treatment in the country.

scholarly journals Decreased colorectal cancer incidence and mortality in a diverse urban population with increased colonoscopy screening

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Jennifer J. Brown ◽  
Charles K. Asumeng ◽  
David Greenwald ◽  
Matthew Weissman ◽  
Ann Zauber ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Risk Factors ◽  
Urban Population ◽  
Ethnic Disparities ◽  
Mortality Rates ◽  
Screening Colonoscopy ◽  
Annual Percent Change ◽  
Cross Sectional ◽  
Incidence And Mortality ◽  
Racial Ethnic

Abstract Background Although colorectal cancer screening has contributed to decreased incidence and mortality, disparities are present by race/ethnicity. The Citywide Colon Cancer Control Coalition (C5) and NYC Department of Health and Mental Hygiene (DOHMH) promoted screening colonoscopy from 2003 on, and hypothesized future reductions in CRC incidence, mortality and racial/ethnic disparities. Methods We assessed annual percent change (APC) in NYC CRC incidence, stage and mortality rates through 2016 in a longitudinal cross-sectional study of NY State Cancer Registry, NYC Vital Statistics, and NYC Community Health Survey (CHS) data. Linear regression tested associations between CRC mortality rates and risk factors. Results Overall CRC incidence rates from 2000 decreased 2.8% yearly from 54.1 to 37.3/100,000 population in 2016, and mortality rates from 2003 decreased 2.9% yearly from 21.0 to 13.9 in 2016 at similar rates for all racial/ethnic groups. Local stage disease decreased overall with a transient increase from 2002 to 2007. In 2016, CRC incidence was higher among Blacks (42.5 per 100,000) than Whites (38.0), Latinos (31.7) and Asians (30.0). In 2016, Blacks had higher mortality rates (17.9), than Whites (15.2), Latinos (10.4) and Asians (8.8). In 2016, colonoscopy rates among Blacks were 72.2%, Latinos 71.1%, Whites 67.2%, and Asians, 60.9%. CRC mortality rates varied by neighborhood and were independently associated with Black race, CRC risk factors and access to care. Conclusions In a diverse urban population, a citywide campaign to increase screening colonoscopy was associated with decreased incidence and mortality among all ethnic/racial groups. Higher CRC burden among the Black population demonstrate more interventions are needed to improve equity.

scholarly journals Trends in Pancreatic Cancer Incidence and Mortality in Lithuania, 1998–2015

2022 ◽  
Vol 19 (2) ◽  
pp. 949
Author(s):  
Povilas Kavaliauskas ◽  
Audrius Dulskas ◽  
Inga Kildusiene ◽  
Rokas Arlauskas ◽  
Rimantas Stukas ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Incidence ◽  
Direct Method ◽  
Tnm Classification ◽  
Mortality Rates ◽  
Incidence Rates ◽  
Entire Study ◽  
Cancer Of The Pancreas ◽  
Incidence And Mortality ◽  
First Time

Background: Pancreatic cancer is one of the deadliest cancers worldwide, and its incidence is increasing. The aim of this study was to examine the time trends in the incidence and mortality rates of pancreatic cancer for the period of 1998–2015 for the first time in Lithuania by sex, age, subsite, and stage. Methods: This study was based on all cases (deaths) of pancreatic cancer diagnosed between 1998 and 2015. Age-standardized incidence (mortality) rates and group-specific rates were calculated for each sex using the direct method (European Standard). TNM classification-based information reported to the cancer registry was grouped into three categories: (1) localized cancer: T1-3/N0/M0; (2) cancer with regional metastasis: any 1-3/N+/M0; (3) advanced cancer: any T/any N/M+. Joinpoint regression was used to provide annual percentage changes (APCs) and to detect points in time where statistically significant changes in the trends occurred. Results: Overall, 8514 pancreatic cancer cases (4364 in men and 3150 in women) were diagnosed and 7684 persons died from cancer of the pancreas. Pancreatic cancer incidence rates were considerably lower for women than for men, with a female:male ratio of 1:2. Incidence rates changed during the study period from 14.2 in 1998 to 15.0/100,000 in the year 2015 in men, and from 6.7 to 9.8/100,000 in women. Incidence rates over the study period were stable for men (APC = 0.1%) and increasing for women by 1.1% per year. Similarly, mortality rates increased in women by 0.9% per year, and were stable in men. During the study period, incidence and mortality rates of pancreatic cancer were close. For the entire study period, rates increased significantly in the 50–74 years age group; only cancer of the head of pancreas showed a decline by 0.9%, while tail and not-specified pancreatic cancer incidence increased by 11.4% and 4.51%, respectively. Conclusions: The increasing pancreatic cancer incidence trend in the Lithuanian population may be related to the prevalence of its main risk factors (smoking, obesity, physical inactivity, diet, and diabetes).

Epidemiology of the Incidence and Mortality of Pancreas Cancer and its Relationship with the Human Development Index (HDI) in the World: An Ecological Study in 2018

2020 ◽  
Vol 26 (40) ◽  
pp. 5163-5173
Author(s):  
Elham Goodarzi ◽  
Ali Hassanpour Dehkordi ◽  
Reza Beiranvand ◽  
Hasan Naemi ◽  
Zaher Khazaei
Keyword(s):  
Pancreatic Cancer ◽  
Human Development ◽  
Cancer Incidence ◽  
Pancreas Cancer ◽  
Malignant Neoplasm ◽  
Developed Countries ◽  
Mortality Rates ◽  
Incidence And Mortality ◽  
The Impact ◽  
Very High

Objective: Pancreatic cancer is one of the leading causes of mortality in developed countries and a lethal malignant neoplasm worldwide. This study aims to evaluate the epidemiology of pancreatic cancer incidence and mortality and its relationship with HDI. Methods: This is a descriptive cross-sectional study that is based on cancer incidence data and cancer mortality rates derived from the GLOBOCAN in 2018. : The incidence and mortality rates of Pancreas as well as Pancreas cancer distribution maps were derived for world countries. The data analysis was conducted using a correlation test, and regression tests were used to evaluate the correlation of the incidence and mortality of Pancreas with HDI. The statistical analysis was carried out by Stata-14, and a significance level of 0.05 was considered. Results: The highest incidence of pancreatic cancer was reported in Asia with 214499 (46.7%) cases and the lowest incidence was related to Oceania with 4529 cases (0.99%). The results showed a positive and significant correlation between incidence (r = 0.764, P <0.0001) and mortality (r = 0.771, P <0.0001) of pancreatic cancer and the HDI index. The results of ANOVA revealed that the highest mean incidence was related to the very high HDI (P <0.0001) and the highest mortality was connected to the very high human development (P <0.0001). The results exhibited that incidence was positively and significantly correlated with GNI (r = 0.497, P <0.0001), MYS (r = 0.746, P <0.0001), LEB (r = 0.676, <0.0001) and EYS (r = 0.738, P <0.0001). Also, a significant positive correlation was found between mortality and GNI (r = 0.507, P <0.0001), MYS (r = 0.745, P <0.0001), LEB (r = 0.679, <0.0001), and EYS (r = 0.748, P <0.0001). Conclusion: Given the higher incidence and mortality of pancreatic cancer in countries with HDI, it is necessary to pay a greater attention to risk factors and appropriate planning to reduce these factors and minimize the impact and mortality rate of this disease.

Sign in / Sign up

Export Citation Format

Share Document